- Home
- STC vs HRMY Comparison
STC vs HRMY Comparison
Compare STC & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STC | HRMY |
|---|---|---|
| Founded | 1893 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | STC | HRMY |
|---|---|---|
| Price | $67.52 | $35.34 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $81.00 | $44.11 |
| AVG Volume (30 Days) | 224.6K | ★ 910.7K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.00% | N/A |
| EPS Growth | ★ 55.17 | 7.97 |
| EPS | 0.55 | 0.55 |
| Revenue | ★ $2,921,636,000.00 | $868,453,000.00 |
| Revenue This Year | $13.62 | $19.75 |
| Revenue Next Year | $7.13 | $12.88 |
| P/E Ratio | $116.82 | ★ $65.09 |
| Revenue Growth | 17.32 | ★ 21.51 |
| 52 Week Low | $57.11 | $25.52 |
| 52 Week High | $78.61 | $40.87 |
Technical Indicators
Market Signals| Indicator | STC | HRMY |
|---|---|---|
| Relative Strength Index (RSI) | 48.34 | 51.31 |
| Support Level | $64.67 | $35.05 |
| Resistance Level | $68.65 | $35.47 |
| Average True Range (ATR) | 2.11 | 1.59 |
| MACD | -0.32 | -0.20 |
| Stochastic Oscillator | 41.77 | 46.08 |
Price Performance
Historical ComparisonAbout STC Stewart Information Services Corporation
Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments: Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.